A phase I study of indole-3-carbinol in women: Tolerability and effects

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 8, 2005, Pages 1953-1960

  Reed, Gregory A ^a,b   Peterson, Kirstin S ^a   Smith, Holly J ^a,b   Gray, John C ^b   Sullivan, Debra K ^b   Mayo, Matthew S ^b   Crowell, James A ^c   Hurwitz, Aryeh ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRONE; 3 INDOLEMETHANOL; ARYLAMINE ACETYLTRANSFERASE; BIOLOGICAL MARKER; CAFFEINE; CYTOCHROME P450 1A2; ESTRADIOL; FOLLITROPIN; GLUTATHIONE TRANSFERASE; LUTEINIZING HORMONE; PLACEBO; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; XANTHINE OXIDASE INHIBITOR;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; ASTHMA; BLOATING; BREAST CANCER; BREAST TENDERNESS; CHRONIC DRUG ADMINISTRATION; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFECT; DRUG TOLERABILITY; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; FOLLICULAR PHASE; HEADACHE; HIGH RISK PATIENT; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE URINE LEVEL; HUMAN; LOOSE FECES; MUSCULOSKELETAL DISEASE; NAUSEA; NEURALGIA; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RASH; RESPIRATORY TRACT DISEASE; SCIATIC NERVE; THORAX PAIN; VOMITING;

ADULT; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; FEMALE; GONADAL STEROID HORMONES; HUMANS; INDOLES; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; SINGLE-BLIND METHOD; TUMOR MARKERS, BIOLOGICAL;

EID: 23844450586     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0121     Document Type: Article

References (46)

1. Wattenberg LW, Loub WD. Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res 1978;38:1410-3.
2. 1 carcinogenesis in rainbow trout by flavone and indole compounds. Carcinogenesis 1984;5:615-9.
3. 6-ethylguanine formation in rainbow trout by indole-3-carbinol, α-naphthoflavone, and Aroclor 1254. Toxicol Appl Pharmacol 1988;96:93-100.
4. Bradlow HL, Michnovicz J, Telang NT, Osborne MP. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 1991;12:1571-4.
5. Chung FL, Morse MA, Eklind KI, Xu Y. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis by compounds derived from cruciferous vegetables and green tea. Ann NY Acad Sci 1993;686:186-201.
6. Kojima T, Tanaka T, Mori H. Chemoprevention of spontaneous endornetrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res 1994;54:1446-9.
7. Grubbs CJ, Steele VE, Casebolt T, et al. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 1995;15:709-16.
8. El Bayoumy K, Upadhyaya P, Desai DH, et al. Effects of 1,4-phenylenebis (methylene)selenocyanate, phenethyl isothiocyanate, indole-3-carbinol, and D-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methyrnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Anticancer Res 1996;16:2709-12.
9. Jin L, Qi M, Chen D-Z, et al. Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HP V16) transgenic mice. Cancer Res 1991;59:3991-7.
10. Mori H, Sugie S, Rahman W, Suzui N. Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5]pyridine-induced mammary carcinogenesis in rats. Cancer Lett 1999;143:195-8.
11. Osborne MP. Chemoprevention of breast cancer. Surg Clin North Am 1999;79:1207-21.
12. Lawrence JA, Malpas PB, Sigman CC, Kelloff GJ. Clinical development of estrogen modulators for breast cancer chemoprevention in premenopausal and postmenopausal women. J Cell Biochem Suppl 2000;34:103-14.
13. Yuan F, Chen D-Z, Liu K, et al. Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer. Anticancer Res 1999;19:1673-80.
14. Rahman KMW, Sarkar FH. Steroid hormone mimics: molecular mechanisms of cell growth and apoptosis in normal and malignant mammary epithelial cells. J Steroid Biochem 2002;80:191-201.
15. Auborn KJ, Fan S, Rosen EM, et al. Indole-3-carbinol is a negative regulator of estrogen. J Nutr 2003;133:2470-5S.
16. Shertzer HG, Senft AP. The micronutrient indole-3-carbinol: implications for disease and chemoprevention. Drug Metab Drug Interact 2000;17:159-88.
17. Ashok BT, Chen Y, Liu X, et al. Abrogation of estrogen-mediated cellular and biochemical effects by indole-3-carbinol. Nutr Cancer 2001;41:180-7.
18. Firestone GL, Bjeldanes LF. Indole-3-carbinol and 3,3′- diindolylmethane antiproliferative signaling pathways control cell-cycle gene transcription in human breast cancer cells by regulating promoter-Sp1 transcription factor interactions. J Nutr 2003;133:2448-55S.
19. Bonnesen C, Eggleston IM, Hayes JD. Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res 2001;61:6120-30.
20. Chinni SR, Sarkar FH. Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin Cancer Res 2002;8:1228-36.
21. Sarkar FH, Rahman KMW, Li Y. Bax translocation to mitochondria is an important event in inducing apoptotic cell death by indole-3-carbinol (I3C) treatment of breast cancer cells. J Nutr 2003;133:2434-9S.
22. Gail MH, Brinton LA, Byar DP, et al. Projecting the individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86.
23. Evans WE, Relling MV, Petros WP, et al. Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children. Clin Pharmacol Ther 1989;45:568-73.
24. Bradlow HL, Sepkovic DW, Klug T, Osborne MP. Application of an improved ELISA assay to the analysis of urinary estrogen metabolites. Steroids 1998;63:406-13.
25. Kashuba AM, Bertino JS, Kearns GL, et al. Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping. Clin Pharmacol Ther 1998;63:540-51.
26. Park CS, Chung WG, Kang JH, et al. Phenotyping of flavin-containing monooxygenase using caffeine metabolism and genotyping of FMO3 gene in a Korean population. Pharmacogenetics 1999;9:155-64.
27. Kashuba AM, Nafziger AN, Kearns GL, et al. Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping. Clin Pharmacol Ther 1998;64:257-68.
28. Hodnick WF, Sartorelli AC. Measurement of dicumarol-sensitive (NADPH-menadione-cytochrome c) oxidoreductase activity results in an artifactual assay of DT-diaphorase in cell sonicates. Anal Biochem 1997;252:165-8.
29. Gupta E, Olopade OI, Ratain MJ, et al. Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent. Clin Cancer Res 1995;1:1133-8.
30. Lang DH, Rettie AE. In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO): metabolism of benzylamine and caffeine by FMO and P450 isoforms. Br J Clin Pharmacol 2000;50:311-4.
31. Muti P, Bradlow HL, Micheli A, et al. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16α-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology 2000;11:635-40.
32. Castagnetta LAM, Granata OM, Traina A, et al. Tissue content of hydroxyestrogens in relation to survival of breast cancer patients. Clin Cancer Res 2002;8:3146-55.
33. Parkinson A. Biotransformation of xenobiotics. In: Klaassen CD, editor. Casarett and Doull's toxicology: the basic science of poisons. New York: McGraw-Hill; 2001. p. 133-224.
34. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998;19:1-27.
35. Katchamart S, Stresser DM, Dehal SS, et al. Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug-drug interactions. Drug Metab Dispos 2000;28:930-6.
36. Cashman JR, Xiong Y, Lin J, et al. In vitro and in vivo inhibition of human flavin monooxygenase form 3 (FMO3) in the presence of dietary indoles. Biochem Pharmacol 1999;58:1047-55.
37. Kovacs SJ, Martin DE, Everitt DE, et al. Urinary excretion of 6β-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations. Clin Pharmacol Ther 1998;63:617-22.
38. Ritter CL, Prigge WF, Reichert MA, Malejka-Giganti D. Oxidations of 17p-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or β-naphthoflavone. Can J Physiol Pharmacol 2001;79:519-32.
39. Bell MC, Crowley-Nowick P, Bradlow HL, et al. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol 2000;78:123-9.
40. Rosen CA, Bryson PC. Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. J Voice 2004;18:248-53.
41. Kelloff GJ, Crowell JA, Steele VE, et al. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr 2000;130:467-713.
42. Sheweita SA, Tilmisany AK. Cancer and phase II drug-metabolizing enzymes. Curr Drug Metab 2003;4:45-58.
43. Ross D, Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol 2004;382:115-44.
44. 1 metabolism. Carcinogenesis 1997;18:1729-39.
45. Nho C, Jeffery E. The synergistic upregulation of phase II detoxication enzymes by glucosinolate breakdown products in cruciferous vegetables. Toxicol Appl Pharmacol 2001;174:146-52.
46. Gordon GB, Prochaska HJ, Yang LY-S. Induction of NAD(P)H:quinone reductase in human peripheral blood lymphocytes. Carcinogenesis 1991;12:2393-6.